Champions Oncology (CSBR) Misses Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $4.84 +0.21%
Financial Fact:
Provision for income taxes: 14K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Provision for income taxes: 14K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q4 EPS of ($0.17), $0.09 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $12.84 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Walmart stock climbs on AI shopping tool expansion
- Datadog stock tumbles 19% despite earnings beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
